Skip to content
Jordan
-
Hikma Pharmaceuticals reports steady growth outlook ahead of AGM, expands inhalation platform
The company forecasts overall revenue growth of 2% to 4% in 2026, with operating profit projected between USD 720 million and USD 770 million.